Kyverna Therapeutics scores $25 mln Series A

Berkeley, California-based Kyverna Therapeutics, a cell therapy company, has secured $25 million in Series A funding.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this